Figure 1.
Proportion of patients developing respiratory events across different types of hematological malignancies. Patients with prolonged neutropenia were those with AML and recipients of allogeneic stem cell transplants. Data for bars 1 and 2 from Rabbat et al,31 Chaoui et al,9 and Azoulay et al.98 Data for bar 3 from Azoulay et al98 and Pichereau et al.122 Data for bar 4 from Orasch et al.10 Data for bar 5 from Kerhuel et al.127 Data for bar 6 from Azoulay et al.5 Data for bar 7 from Rabbat et al,31 Chaoui et al,9 and Azoulay et al.98 Data for bar 8 from Algrin et al128 and Wohlfarth et al.28 CAR, chimeric antigen receptor.

Proportion of patients developing respiratory events across different types of hematological malignancies. Patients with prolonged neutropenia were those with AML and recipients of allogeneic stem cell transplants. Data for bars 1 and 2 from Rabbat et al,31 Chaoui et al,9 and Azoulay et al.98 Data for bar 3 from Azoulay et al98 and Pichereau et al.122 Data for bar 4 from Orasch et al.10 Data for bar 5 from Kerhuel et al.127 Data for bar 6 from Azoulay et al.5 Data for bar 7 from Rabbat et al,31 Chaoui et al,9 and Azoulay et al.98 Data for bar 8 from Algrin et al128 and Wohlfarth et al.28 CAR, chimeric antigen receptor.

Close Modal

or Create an Account

Close Modal
Close Modal